Mesenchymal stem cell therapy reduces liver stiffness in cirrhotic patients a treatment approach
Mesenchymal stem cell (MSC) therapy shows promise in reducing liver stiffness in cirrhosis. This analytical review explores the treatment approach, examining efficacy and potential benefits of MSCs in mitigating fibrosis and improving liver function in cirrhotic patients. Learn more.





